All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @rudebthonest on TikTok · 81s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @rudebthonest's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00just drew it up.
  2. 0:02Oh, baby, not me shaking again.
  3. 0:07Okay, so this is me going into week two.
  4. 0:11We're just gonna talk me through it.
  5. 0:14We're getting a little alcohol swipe.
  6. 0:16I checked the video.
  7. 0:17I did this side, so I need to do this side.
  8. 0:20So here we go.
  9. 0:22Okay, okay, let's go.
  10. 0:37So last week did this side.
  11. 0:41So this week we're doing this side.
  12. 0:46Listen, I still get nervous every time I do this.
  13. 0:50Like I put a lot of, I guess I think too much about it.
  14. 0:54I don't know.
  15. 0:56I still do not like shots.
  16. 0:58I'm just not shaking, but it's, I still don't like it.
  17. 1:02Cause now the skin is not as like, but it's fine.
  18. 1:13Here we go.
  19. 1:17Now the week down, let's get it.
  20. 1:19Let's get it.

@rudebthonest's GLP-1 workout claims need context

RudeBtHonest | Wellness+Life💕

TikTok creator

77.1K viewsWatch on TikTok →

Quick answer

The creator is in week two of GLP-1 receptor agonist therapy, demonstrating subcutaneous self-injection technique including alcohol site preparation and left-right abdominal rotation. Her practice of alternating injection sides aligns with FDA-labeled guidance to prevent lipodystrophy, though the necessity of alcohol swabbing before home subcutaneous injection is not supported by current evidence as a mandatory infection-prevention step. New users in the early titration phase should also be counseled on expected gastrointestinal side effects that the video does not address.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @rudebthonest's GLP-1 workout claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@rudebthonest's GLP-1 workout claims need context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@rudebthonest's GLP-1 workout claims need context" from RudeBtHonest | Wellness+Life💕. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is in week two of GLP-1 receptor agonist therapy, demonstrating subcutaneous self-injection technique including alcohol site preparation and left-right abdominal rotation.

The reason this review is not generic is the source wording and the canonical claim label "glp1 they lied i still get scared but damn those results at the." In this clip, the useful excerpt is: "just drew it up." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Alcohol swabbing before home subcutaneous injection has no documented benefit in reducing infection rates and is considered optional by current evidence, not mandatory (Spollett et al.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is in week two of GLP-1 receptor agonist therapy, demonstrating subcutaneous self-injection technique including alcohol site preparation and left-right abdominal rotation.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is in week two of GLP-1 receptor agonist therapy, demonstrating subcutaneous self-injection technique including alcohol site preparation and left-right abdominal rotation. Her practice of alternating injection sides aligns with FDA-labeled guidance to prevent lipodystrophy, though the necessity of alcohol swabbing before home subcutaneous injection is not supported by current evidence as a mandatory infection-prevention step. New users in the early titration phase should also be counseled on expected gastrointestinal side effects that the video does not address.
  • Site rotation across abdomen, thigh, and upper arm is FDA-recommended for GLP-1 pens; staying in one zone risks lipodystrophy that impairs drug absorption (Heinemann et al., 2023, Diabetes Technology and Therapeutics).
  • Alcohol swabbing before home subcutaneous injection has no documented benefit in reducing infection rates and is considered optional by current evidence, not mandatory (Spollett et al., 2014, Journal of Diabetes Science and Technology).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Site rotation across abdomen, thigh, and upper arm is FDA-recommended for GLP-1 pens; staying in one zone risks lipodystrophy that impairs drug absorption (Heinemann et al., 2023, Diabetes Technology and Therapeutics).
  • Alcohol swabbing before home subcutaneous injection has no documented benefit in reducing infection rates and is considered optional by current evidence, not mandatory (Spollett et al., 2014, Journal of Diabetes Science and Technology).
  • Needle anxiety in week two of injectable therapy is clinically normal. Meneghini et al. (2021) found injection fear is one of the top reasons patients delay or quit injectable therapies, making normalization content like this video potentially useful for adherence.
  • If you do use an alcohol swab, the site must be fully dry before injection. Injecting through wet alcohol can cause unnecessary stinging and minor skin irritation.
  • Week two of GLP-1 titration is commonly when gastrointestinal side effects (nausea, bloating) peak for new users. This video does not address that, so new starters should not use it as a complete preparation guide.
  • This creator did not make dosing claims, recommend specific drugs, or present compounded products as equivalent to brand-name medications, which puts her ahead of a significant portion of GLP-1 content on TikTok from a compliance standpoint.
  • Injection technique guidance should come from a licensed prescriber or pharmacist who has reviewed your individual health profile, not from social media content alone, regardless of how authentic and well-intentioned it is.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @rudebthonest actually say?

Honestly, not much in the way of medical claims, which is kind of refreshing. The creator showed herself doing her second weekly GLP-1 injection, mentioning she "still get nervous every time" and that she alternated from last week's side to the opposite abdomen this week. She wiped the site with alcohol, injected, and let the footage do the talking. No dosing advice, no miracle promises. Just a nervous person doing their shot.

The implicit claims here are behavioral: that rotating injection sites is the right move, that alcohol swabbing is necessary prep, and that ongoing anxiety about self-injection is normal. Those are actually worth examining, because not all of them hold up the way you might expect.

Does the science back this up?

Site rotation is legitimately recommended, and she is doing it correctly. The anxiety part is also well-documented. But the alcohol swab before a subcutaneous injection? That one is more complicated than most people realize.

On site rotation: the FDA prescribing information for semaglutide (Wegovy) explicitly recommends rotating injection sites between the abdomen, thigh, and upper arm. Staying in the same spot repeatedly can lead to lipodystrophy, a localized change in fat tissue that impairs drug absorption. A 2023 review in Diabetes Technology and Therapeutics (Heinemann et al.) confirmed that lipodystrophy from poor rotation is still underdiagnosed and affects insulin and GLP-1 absorption meaningfully.

On alcohol swabs: current guidance from the American Diabetes Association and most pen injection training programs actually considers pre-injection alcohol swabbing optional for self-injection in a home setting. The concern is that alcohol left on the skin that hasn't fully dried can cause a brief stinging sensation. It doesn't increase infection risk to skip it in a clean home environment. So she's not wrong to use one, but it's not the protective step most people assume it is.

What did they get wrong (or right)?

She got the rotation right. Switching sides week to week is exactly what is recommended, and it matters more than most new users realize. Credit where it is due.

The alcohol swab is a minor misstep in the sense that it's taught as mandatory when the evidence says it's more of a habit than a clinical requirement. A 2014 paper in the Journal of Diabetes Science and Technology (Spollett et al.) noted that routine alcohol skin prep before subcutaneous self-injection has no documented benefit in reducing infection rates for home users. The bigger risk factor for injection site problems is actually injection technique and rotation failure, not whether you swabbed.

What she did not do, which is genuinely worth noting, is say anything about the dose, the drug name, or encourage anyone to self-prescribe. That kind of restraint is rare in GLP-1 content and should be acknowledged. Too many creators in this space are effectively walking advertisements for specific dosing protocols. She was not doing that.

What should you actually know?

If you are starting GLP-1 therapy and watching creators like this for guidance, here is what actually matters clinically.

  • Rotate injection sites systematically. The abdomen, outer thigh, and upper arm are all approved sites for most GLP-1 pens. Moving between them, not just left-to-right on the same zone, reduces tissue damage over time.
  • Injection anxiety is real and common. A 2021 study in Patient Preference and Adherence (Meneghini et al.) found needle anxiety is one of the top reasons people delay or abandon injectable therapies. Normalizing it, as this creator does, has genuine value for adherence.
  • Alcohol swabs are not a clinical requirement at home. If you use one, let it dry completely before injecting. If you skip it, that is not a safety failure.
  • Week two is often when side effects peak for many users. Nausea, injection site redness, and fatigue are common in the titration phase. None of that was discussed here, and a new user watching this might not be prepared.

The creator's lived experience content has real value. But it should not replace the injection training that comes with a legitimate prescription through a licensed provider who actually reviews your health history.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

RudeBtHonest | Wellness+Life💕 · TikTok creator

77.1K views on this video

They lied, I still get scared, but damn those results at the end of the video 😳🤯 #rudebthonest #fyp #glp1 #workout #curvy

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about site rotation across abdomen, thigh,?

Site rotation across abdomen, thigh, and upper arm is FDA-recommended for GLP-1 pens; staying in one zone risks lipodystrophy that impairs drug absorption (Heinemann et al., 2023, Diabetes Technology and Therapeutics).

What does the video say about alcohol swabbing before home subcutaneous injection has no documented benefit?

Alcohol swabbing before home subcutaneous injection has no documented benefit in reducing infection rates and is considered optional by current evidence, not mandatory (Spollett et al., 2014, Journal of Diabetes Science and Technology).

What does the video say about needle anxiety in week two of injectable therapy?

Needle anxiety in week two of injectable therapy is clinically normal. Meneghini et al. (2021) found injection fear is one of the top reasons patients delay or quit injectable therapies, making normalization content like this video potentially useful for adherence.

What does the video say about if you do use an alcohol swab, the site must?

If you do use an alcohol swab, the site must be fully dry before injection. Injecting through wet alcohol can cause unnecessary stinging and minor skin irritation.

What does the video say about week two of glp-1 titration?

Week two of GLP-1 titration is commonly when gastrointestinal side effects (nausea, bloating) peak for new users. This video does not address that, so new starters should not use it as a complete preparation guide.

What does the video say about this creator did not make dosing claims, recommend specific drugs,?

This creator did not make dosing claims, recommend specific drugs, or present compounded products as equivalent to brand-name medications, which puts her ahead of a significant portion of GLP-1 content on TikTok from a compliance standpoint.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by RudeBtHonest | Wellness+Life💕, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.